- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05050565
Psychological Flexibility in Chronic Pain Populations; an Observation- and Validation Study
Chronic pain in general is a substantial problem and is a source of a great deal of disability and suffering. It is known that processes like stigma and psychological flexibility (PF) play a significant role in these outcomes. At the same time, there are many specific chronic pain disorders and there is less knowledge about similarities and differences between these specific conditions, whether the role of processes like these vary between conditions or not. For studies that can address this to be done in Sweden, there will need to be adequately translated and validated measures of the key processes identified.
The main aim of the current study is to look at whether the role of PF and stigma in pain-related outcomes differ across pain conditions. In support of that, a secondary aim is to first validate measures of stigma and PF in chronic pain populations. For this secondary aim, the current study seeks to investigate the factor structure, construct - and criterion validity, internal consistency, and test-retest reliability of a Swedish version of the Multidimensional Psychological Flexibility Inventory (MPFI) as well as of a Swedish version of the Stigma Scale for Chronic Illnesses (SSCI-8).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Chronic pain is related to impaired everyday functioning and social adjustment, such as working ability or engaging in recreational activities, and to emotional suffering, such as depression. Sexual functioning and satisfaction may be impaired for patients with vulvodynia and in some cases for patients with endometriosis. Pain seems to interfere with sexual functioning even for people with low back pain and fibromyalgia. Chronic pain is also related to anxiety, and the chronic pain literature often highlights the role of catastrophizing thoughts in exacerbating the experience of pain. Stigma and psychological flexibility (PF) appear to play a role in the suffering endured by people with chronic pain, but it is less clear how these processes differ, or not, between specific pain conditions such as, but not limited to, fibromyalgia, chronic low back pain, endometriosis and vulvodynia. Thus, the main aim of the current study is to investigate this by having participants with various chronic pain conditions fill out measures on stigma and psychological flexibility, and to see how these processes differ across conditions.
However, there is currently a lack of measures in Swedish to adequately capture stigma and psychological flexibility satisfactory. A secondary aim is thus to validate a Swedish version of the Multidimensional Psychological Flexibility Inventory (MPFI) and the Stigma Scale for Chronic Illnesses (SSCI-8).
In order to establish construct- and criterion validity, scores on these measures will be compared to that of related outcomes such as specific facets of psychological flexibility, pain interference, depression, social adjustment, and catastrophizing. In addition, test-retest reliability, internal consistency and factor structures for each measure, the SSCI-8 and the MPFI will be examined.
If eligible, participants will be directed to answer questionnaires via RedCap, a GDPR-compliant mobile application. After finishing the questionnaires, the participants will be reminded after two weeks in order to fill out the same questionnaires once more. At this second time point, questions regarding participant characteristics such as demography and pain background will be excluded.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Uppland
-
Uppsala, Uppland, Sweden, 75236
- Department of Psychology, Uppsala University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Aged 18 or over
- Suffering from chronic or recurrent pain for ≥ 3 months
- Access to an internet enabled phone/computer/tablet
- Fluent in written Swedish
- Willing to be contacted during the study
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Stigma Scale for Chronic Illnesses (SSCI-8)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
The SSCI-8 is an eight-item measure including items reflecting both enacted and internalized stigma.
Minimum score is 8, and maximum score is 40.
Higher scores indicate a greater degree of stigma.
It is administered alongside the other outcomes in order to establish validity.
It is also administered in order to examine similarities and dissimilarities between different chronic pain conditions in the stigma experience and in its relationship to the other outcome measures.
The SSCI-8 will be administered a second time in order to examine temporal stability of the instrument.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Multidimensional Psychological Flexibility Inventory (MPFI)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
The MPFI is a 60-item measure reflecting all facets of psychological flexibility.
The measure is divided into two overarching dimensions, namely inflexibility and flexibility.
Each dimension contains 30 items, and in each dimension the minimum score is an average of 1 across the 30 items, while the maximum score is an average of 6 across the 30 items.
For the inflexibility part of the MPFI, a higher average score indicates higher inflexibility.
For the flexibility part of the MPFI, a higher average score indicates higher flexibility.
The MPFI is administered alongside the other outcomes in order to establish validity.
It is also administered in order to examine similarities and dissimilarities between different chronic pain conditions in psychological flexibility and in its relationship to the other outcome measures.
The MPFI will be administered a second time in order to examine temporal stability of the instrument.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Chronic Pain Acceptance Questionnaire (CPAQ-8)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
An eight-item measure on pain acceptance.
The minimum score is 0, and the maximum score is 48.
Higher scores indicate higher pain acceptance.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Committed Action Questionnaire 8-item version (CAQ-8)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
An eight-item measure on committed action.
The minimum score is 0, and the maximum score is 48.
Higher scores indicate higher levels of committed action.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Five Facet Mindfulness Questionnaire (FFMQ) - acting with awareness facet
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
An eight-item subscale on acting with awareness.
The minimum score is 8, and the maximum score is 40.
It is possible to divide the summary score into an average score.
If so, the minimum average score is 1, and the maximum average score is 5. Higher scores indicate lower levels of acting with awareness.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
A nine-item measure on symptoms of depression, with a minimum score of 0 and a maximum score of 27.
Higher scores indicate higher levels of depression.
The scale also includes as additional item regarding how the depressive symptoms have interfered with everyday functioning.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Coping Strategy Questionnaire (CSQ) - catastrophizing subscale
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
A six-item subscale on pain catastrophizing.
The minimum score is 0 and maximum score is 36.
Higher scores indicate higher levels of catastrophizing.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Work and Social Adjustment Scale (WSAS)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
The WSAS is a five-item measure on social adjustment.
The minimum score is 0 and maximum score is 40.
Higher scores indicate lower work and social adjustment.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Brief Pain inventory - short form (BPI-SF)
Time Frame: Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
For this study, two items on pain severity, one regarding average pain severity during the last week and one regarding pain severity at the current moment, and nine items on pain interference will be used.
Two out of the nine pain interference items, exploring how pain interferes with sexual activities and enjoyment of sex, have been created and added by the research team.
The two pain severity items are each scored from 0 to 10, with 0 indicating the least amount of pain and 10 indicating the highest amount of pain.
The original seven pain interference items are each scored in the same way, but can also together generate an average score, with the minimum average score then being 0 and the maximum average score being 10.
A higher score indicates a higher level of pain interference.
The two pain interference items created by the research team are each scored from 0 to 10, with 0 indicating the least amount of interference and 10 indicating the highest amount of interference.
|
Measured immediately following participant consent to undertake survey, and again two weeks thereafter
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Monica Buhrman, phd, Uppsala University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20210629
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic
Clinical Trials on Experiences of stigma and psychological flexibility in chronic pain participants
-
Kirby InstituteCompleted
-
Universiteit AntwerpenCompletedStudy Focus: Prescribing of DrugsBelgium
-
Baskent UniversityOkan UniversityCompleted
-
Vejle HospitalTerminatedNon Small Cell Lung CancerDenmark
-
Ain Shams UniversityRecruiting
-
Bursa Yüksek İhtisas Education and Research HospitalCompletedIlioinguinal Nerve BlockTurkey
-
University GhentBijzonder onderzoeksfonds (BOF)CompletedPain | TinnitusBelgium
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...UnknownNeuropathic Pain | Cancer Pain | Persistent Post-surgical PainUnited Kingdom
-
Central European Society for Anticancer Drug ResearchCompletedMetastatic Renal Cell CarcinomaGermany
-
London School of Hygiene and Tropical MedicineKwame Nkrumah University of Science and TechnologyCompletedPregnancy | Malaria | AnaemiaGhana